Corresponding to the chapters in Kee's Pharmacology: A Patient-Centered Nursing Process Approach, 8th Edition, this study guide offers practical activities to help you review and remember essential nursing pharmacology. Hands-on exercises include study questions, case studies, and NCLEX® review questions, making it easier to apply your knowledge to clinical practice and develop clinical reasoning skills.
NCLEX® review questions
in each chapter include application-level questions and alternate-item format questions.
Case studies enhance your understanding of nursing responsibilities in therapeutic pharmacology.
Medications and Calculations chapter offers additional opportunities to test your knowledge and skill in drug dosage calculation.
75 sample drug labels familiarize you with the real labels you will see in clinical practice.
Answers for all exercises are provided at the back of the book to make studying easier.
Study questions are provided in formats including matching, completion, and crossword puzzles.
New to this Edition
NEW! Updated content
reflects the changes to Kee's Pharmacology textbook.
NEW! Case study questions focus on developing your clinical reasoning skills.
NEW! Rationales are added to the answer key for selected application-level questions and case study questions.
NEW safety icons emphasize the nurse's role in patient safety.
NEW! Case studies now feature open-ended questions to promote development of clinical reasoning skills.
Unit I: Introduction to Pharmacology 1. Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases 2. The Drug Approval Process 3. Cultural and Pharmacogenetic Considerations 4. Drug Interactions and Over-the-Counter Drugs 5. Drugs of Abuse 6. Herbal Therapies 7. Pediatric Pharmacology 8. Geriatric Pharmacology 9. Collaboration in Community Settings NEW QSEN focus! 10. The Role of the Nurse in Drug Research Unit II: A Nurse's Perspective of Pharmacology 11. The Nursing Process in Patient-Centered Pharmacotherapy NEW QSEN focus! 12. Safety and Quality in Pharmacotherapy NEW QSEN focus! 13. Medication Administration Unit III: Drug Calculations 14. Medications and Calculations Section 14A: Systems of Measurement with Conversion Section 14B: Methods for Calculation Section 14C: Calculations of Oral Dosages Section 14D: Calculations of Injectable Dosages Section 14E: Calculations of Intravenous Fluids Section 14F: Pediatric Drug Calculations Unit IV: Nutrition and Electrolytes 15. Vitamin and Mineral Replacement 16. Fluid and Electrolyte Replacement 17. Nutritional Support Unit V: Autonomic Nervous System Agents 18. Adrenergic Agonists and Adrenergic Blockers 19. Cholinergic Agonists and Anticholinergics Unit VI: Neurologic and Neuromuscular Agents 20. Central Nervous System Stimulants 21. Central Nervous System Depressants 22. Anticonvulsants 23. Drugs for Neurological Disorders: Parkinsonism and Alzheimer's Disease 24. Drugs for Neuromuscular Disorders: Myasthenia Gravis, Multiple Sclerosis, and Muscle Spasms Unit VII: Pain and Inflammation Management Agents 25. Antiinflammatory Drugs 26. Nonopioid and Opioid Analgesics Unit VIII: Psychiatric Agents 27. Antipsychotics and Anxiolytics 28. Antidepressants and Mood Stabilizers Unit IX: Antibacterial and Antiinfective Agents 29. Penicillins and Cephalosporins 30. Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones 31. Sulfonamides Unit X: Additional Antiinfective Agents 32. Antituberculars, Antifungals, Peptides, and Metronidazole 33. Antivirals, Antimalarials, and Anthelmintics 34. Drugs for Urinary Tract Disorders Unit XI: Immunologic Agents 35. HIV- and AIDS-Related Drugs 36. Vaccines Unit XII: Antineoplastic Agents 37. Anticancer Drugs 38. Targeted Therapies to Treat Cancer 39. Biologic Response Modifiers Unit XIII: Respiratory Agents 40. Drugs for Upper Respiratory Disorders 41. Drugs for Lower Respiratory Disorders Unit XIV: Cardiovascular Agents 42. Cardiac Glycosides, Antianginals, and Antidysrhythmics 43. Diuretics 44. Antihypertensives 45. Anticoagulants, Antiplatelets, and Thrombolytics 46. Antihyperlipidemics and Peripheral Vasodilators Unit XV: Gastrointestinal Agents 47. Drugs for Gastrointestinal Tract Disorders 48. Antiulcer Drugs Unit XVI: Eye, Ear, and Skin Agents 49. Drugs for Eye and Ear Disorders 50. Drugs for Dermatologic Disorders Unit XVII: Endocrine Agents 51. Endocrine Drugs: Drugs for Pituitary, Thyroid, Parathyroid, and Adrenal Disorders 52. Antidiabetics Unit XVIII: Reproductive and Gender-Related Agents 53. Female Reproductive Cycle I: Pregnancy and Preterm Labor Drugs 54. Female Reproductive Cycle II: Labor, Delivery, and Preterm Neonatal Drugs 55. Postpartum and Newborn Drugs 56. Drugs for Women's Reproductive Health and Menopause 57. Drugs for Men's Health and Reproductive Disorders 58. Drugs for Disorders in Women's Health, Infertility, and Sexually Transmitted Infections Unit XIX: Emergency Agents 59. Adult and Pediatric Emergency Drugs
By Linda E. McCuistion, PhD, RN, ANP, CNS, Professor, South University, Richmond Campus, Glen Allen, Virginia; Joyce LeFever Kee, MS, RN, Associate Professor Emerita, School of Nursing, College of Health Sciences, University of Delaware, Newark, Delaware and Evelyn R. Hayes, PhD, MPH, FNP-BC, Professor, School of Nursing, College of Health Sciences, University of Delaware, Newark, Delaware